{"id":"W4403505143","doi":"10.1016/j.esmoop.2024.103937","title":"Response to: Cholangiocarcinoma patients with FGFR2 fusions/rearrangements but primary refractory to pemigatinib: the real challenge?","year":2024,"lang":"en","type":"letter","venue":"ESMO Open","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medac; BeiGene; Ipsen; Incyte; Eisai; Sanofi; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Servier; Amgen","keywords":"Refractory (planetary science); Primary (astronomy); Cancer research; Medicine; Internal medicine; Oncology; Biology; Astrobiology; Physics; Astrophysics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000791969,0.0005345328,0.0004088674,0.0001908242,0.0002288347,0.0003484932,0.002377234,0.0006435759,0.0002062859],"category_scores_gemma":[0.0002053833,0.000366776,0.0001377874,0.0002815963,0.0001088824,0.00001443922,0.003478166,0.001362715,0.0008663121],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001776541,"about_ca_system_score_gemma":0.0004744983,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007358926,"about_ca_topic_score_gemma":0.0002033875,"domain_scores_codex":[0.9960829,0.0006197668,0.0003661448,0.001254147,0.000906,0.0007710563],"domain_scores_gemma":[0.9974919,0.0001212119,0.0001178375,0.00177341,0.0002497699,0.0002458872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002684042,0.00007891255,0.001907288,0.0001031187,0.0002359744,0.0001407029,0.0002978297,0.00000130776,0.006151359,0.000001211798,0.9874221,0.0009761567],"study_design_scores_gemma":[0.0006898728,0.001928806,0.08346157,0.0002558384,0.0000385155,0.000004286761,0.00003673266,2.761868e-7,0.001088913,0.000006098498,0.9120021,0.0004869672],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.6942853,0.0001253467,0.000006202063,0.2866224,0.0004729393,0.003972961,0.0007421557,0.00004110155,0.01373165],"genre_scores_gemma":[0.19004,0.0001800315,0.001331156,0.6682042,0.004749808,0.002641963,0.01013183,0.0009519882,0.121769],"genre_candidate":"commentary","genre_consensus":null,"teacher_disagreement_score":0.5042453,"threshold_uncertainty_score":0.9999116,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02058377810227568,"score_gpt":0.2860546329042308,"score_spread":0.2654708548019551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}